卡塔尔波尔的多方面的治疗潜力,一种皮糖类糖化物:一个更新的综合性审查
Mennat-Allah M Hassan1, Mohamed I Fahmy2, Hany N Azzam3
1Department of Pharmacology & Toxicology Department, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt.
Inflammopharmacology
|March 18, 2025
概括
卡塔尔波尔 (Catalpol) 是一种虹膜糖化物,在治疗糖尿病,神经元疾病和炎症方面表现有前途. 它的抗炎和抗氧化特性是其多样化的治疗潜力的关键.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 卡塔尔波尔 (Catalpol) 是一种具有公认药用重要性的虹膜类葡萄糖体.
- 它正在研究糖尿病,神经元疾病和炎症性疾病的治疗应用.
研究的目的:
- 审查catalpol.pol的生物影响.
- 阐明其各种药理作用背后的机制.
主要方法:
- 使用关键字"Catalpol"进行文献搜索.
- 搜索的数据库包括谷歌学者,PubMed和EKB.
主要成果:
- 在实验模型中,Catalpol表现出抗糖尿病,心血管保护,神经保护,抗癌,肝保护,抗炎和抗氧化作用.
- 关键机制涉及强大的抗炎和抗氧化活性.
结论:
- 卡塔尔波尔显示出广泛的生物效应和治疗潜力.
- 需要进一步的研究来确认临床疗效和优化其医疗用途.
相关概念视频
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...


